These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15204011

  • 21. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S, Pinto A, De Carvalho M.
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [Abstract] [Full Text] [Related]

  • 22. Respiratory function in amyotrophic lateral sclerosis.
    Iłzecka J, Stelmasiak Z, Balicka G.
    Neurol Sci; 2003 Nov; 24(4):288-9. PubMed ID: 14658052
    [Abstract] [Full Text] [Related]

  • 23. Outcome measures for early phase clinical trials.
    Gordon PH, Cheng B, Montes J, Doorish C, Albert SM, Mitsumoto H.
    Amyotroph Lateral Scler; 2007 Oct; 8(5):270-3. PubMed ID: 17852017
    [Abstract] [Full Text] [Related]

  • 24. A clinical trial of verapamil in amyotrophic lateral sclerosis.
    Miller RG, Smith SA, Murphy JR, Brinkmann JR, Graves J, Mendoza M, Sands ML, Ringel SP.
    Muscle Nerve; 1996 Apr; 19(4):511-5. PubMed ID: 8622731
    [Abstract] [Full Text] [Related]

  • 25. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G.
    Neurology; 2008 Jan 15; 70(3):222-5. PubMed ID: 18195267
    [Abstract] [Full Text] [Related]

  • 26. Trial of celecoxib in amyotrophic lateral sclerosis.
    Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB.
    Ann Neurol; 2006 Jul 15; 60(1):22-31. PubMed ID: 16802291
    [Abstract] [Full Text] [Related]

  • 27. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ.
    Arch Neurol; 2007 Feb 15; 64(2):232-6. PubMed ID: 17296839
    [Abstract] [Full Text] [Related]

  • 28. The value of database controls in pilot or futility studies in ALS.
    Czaplinski A, Haverkamp LJ, Yen AA, Simpson EP, Lai EC, Appel SH.
    Neurology; 2006 Nov 28; 67(10):1827-32. PubMed ID: 17130417
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
    Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R, Western ALS Study Group.
    Lancet Neurol; 2007 Dec 28; 6(12):1045-53. PubMed ID: 17980667
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).
    Yoshino H, Kimura A.
    Amyotroph Lateral Scler; 2006 Dec 28; 7(4):241-5. PubMed ID: 17127563
    [Abstract] [Full Text] [Related]

  • 32. [Survival in amyotrophic lateral sclerosis].
    Alcaz S, Jarebinski M, Pekmezović T, Marinković Z, Apostolski S.
    Srp Arh Celok Lek; 1997 Dec 28; 125(1-2):19-23. PubMed ID: 17974351
    [Abstract] [Full Text] [Related]

  • 33. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
    Scelsa SN, MacGowan DJ, Mitsumoto H, Imperato T, LeValley AJ, Liu MH, DelBene M, Kim MY.
    Neurology; 2005 Apr 12; 64(7):1298-300. PubMed ID: 15824372
    [Abstract] [Full Text] [Related]

  • 34. [Clinical trials of ultra-high-dose methylcobalamin in ALS].
    Izumi Y, Kaji R.
    Brain Nerve; 2007 Oct 12; 59(10):1141-7. PubMed ID: 17969354
    [Abstract] [Full Text] [Related]

  • 35. Xaliproden: SR 57746, SR 57746A, xaliproden hydrochloride, xaliprodene.
    Drugs R D; 2003 Oct 12; 4(6):386-8. PubMed ID: 14584974
    [Abstract] [Full Text] [Related]

  • 36. [Primary study of diaphragmatic electromyography in amyotrophic lateral sclerosis patients].
    Zhuang L, Tang X, Fan D, Xu X, Li B, Du H, Jiang J.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1385-7. PubMed ID: 12509919
    [Abstract] [Full Text] [Related]

  • 37. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M, Mogi M, Higaki N, Tateishi T, Ohyagi Y, Horiuchi M, Miki T, Kira JI.
    Acta Neurol Scand; 2009 May 25; 119(5):341-4. PubMed ID: 18798831
    [Abstract] [Full Text] [Related]

  • 38. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, Rowland LP, Levin B, Mitsumoto H.
    Neurology; 2005 Jan 11; 64(1):38-43. PubMed ID: 15642901
    [Abstract] [Full Text] [Related]

  • 39. Natural history of young-adult amyotrophic lateral sclerosis.
    Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, Lo Monaco M, Lippi G, Tonali P.
    Neurology; 2008 Sep 16; 71(12):876-81. PubMed ID: 18596241
    [Abstract] [Full Text] [Related]

  • 40. High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.
    Lange DJ, Lechtzin N, Davey C, David W, Heiman-Patterson T, Gelinas D, Becker B, Mitsumoto H, HFCWO Study Group.
    Neurology; 2006 Sep 26; 67(6):991-7. PubMed ID: 17000967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.